AlphAIAlphAI — Financial news for AI agents
investing.comAUG 202 min read$RBLX

Cathie Wood’s ARK sells Roblox stock, buys Broadcom and Cloudflare

ARK ETFs sold 501,466 Roblox (RBLX) shares for $18.89M and 203,242 10X Genomics (TXG) shares for $11.31M. They bought 55,548 Broadcom (AVGO) shares for $21.11M, 60,805 Cloudflare (NET) shares for $18.32M, and 78,756 Cerebras (CBRS) shares for $17.33M. Other trades included Rocket Lab (RKLB), Ionis (IONS), CareDx (CDNA), and Securitize (SECZ).

Original reporting
investing.com
Published Aug 20, 2026, 12:04 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 3:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$RBLX
Bearish
medium confidence
Mentioned
$RBLX · $AVGO · $NET · $CBRS · $TXG · $RKLB
Relevance
5/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$RBLXBearishLow
01

Why it matters

The fund's moves signal a tilt toward semiconductor and cloud services while trimming exposure to gaming and biotech.

02

Market read

Fund reallocation may influence short‑term price dynamics in the listed stocks, especially AVGO and NET.

03

What to watch

ARK's broader portfolio rebalancing and cash management needs may drive trades more than company fundamentals.

Relevance 5/10Novelty 5/10Timing: post‑market Aug 19

Background

ARK Investment Management disclosed its daily trades for Aug 19, highlighting shifts between growth and infrastructure holdings.

Company-level read

Ticker impact

$RBLXBearishMedium confidence
Context

ARK sold 501,466 shares of Roblox Corp (RBLX) for $18.9M.

Expected impact

Downward pressure on RBLX price.

Evidence & confidence

Large sell order by a high‑profile fund may signal reduced confidence.

$AVGOBullishMedium confidence
Context

ARK bought 55,548 shares of Broadcom Inc (AVGO) for $21.1M.

Expected impact

Potential upside for AVGO.

Evidence & confidence

Fund addition may boost investor sentiment.

$NETBullishMedium confidence
Context

ARK purchased 60,805 shares of Cloudflare Inc (NET) for $18.3M.

Expected impact

Possible price lift for NET.

Evidence & confidence

Fund buying often supports short‑term price gains.

$CBRSBullishMedium confidence
Context

ARK bought 78,756 shares of Cerebras Systems Inc (CBRS) for $17.3M.

Expected impact

Likely supportive effect on CBRS.

Evidence & confidence

AI‑focused fund adds credibility to Cerebras.

$TXGBearishMedium confidence
Context

ARK sold 203,242 shares of 10X Genomics Inc (TXG) for $11.3M.

Expected impact

Downward pressure on TXG.

Evidence & confidence

Large sell may indicate concerns about the biotech.

$RKLBNeutralLow confidence
Context

ARK bought 34,370 shares of Rocket Lab Corp (RKLB) for $2.7M.

Expected impact

Limited impact on RKLB.

Evidence & confidence

Small size relative to market cap.

$IONSNeutralLow confidence
Context

ARK bought 18,499 shares of Ionis Pharmaceuticals Inc (IONS) for $1.1M.

Expected impact

Minimal effect on IONS.

Evidence & confidence

Trade size is modest.

$CDNABearishLow confidence
Context

ARK sold 27,486 shares of CareDx Inc (CDNA) for $1.27M.

Expected impact

Slight downward pressure on CDNA.

Evidence & confidence

Trade is small but adds to sell pressure.

Market effects

Sector

Increased ARK exposure to semiconductors and cloud infrastructure may boost sector sentiment.

Regional

U.S. tech and biotech equities see modest rebalancing due to fund activity.

Global

Limited; primarily affects U.S. listed tech and biotech stocks.

Counterpoint

What could challenge this read

ARK's sell‑off in Roblox could be a short‑term overreaction; the stock may rebound.

Key entities

  • Person
    Cathie Wood

    Founder of ARK Investment Management.

  • Firm
    ARK Investment Management

    Active manager of several thematic ETFs.

Read at source← All news

Related articles

SEP 17
$RKLBMed

Rocket Lab Is Playing a Much Bigger Game Than Rocket Launches, Eyes 90% Upside

Rocket Lab (RKLB) reported record Q2 revenue of $234.07 million, up 62% YoY, with a $2.36 billion backlog. The company is expanding beyond launches, targeting $870M in annual revenue from the pending Iridium deal. 24/7 Wall St. set a $120.88 price target, implying 90% upside, citing growth opportunities and risks like Neutron delays and integration challenges.

aol.com3 min
SEP 17
$RKLBMedAI 8/10

Rocket Lab's Revenue Could Top $1.5 Billion in 2027 Without Iridium, Investor Calls Stock a Speculative Buy — BigGo Finance

Rocket Lab (RKLB) reported Q2 2026 revenue of $234M, up 62% YoY, with space systems revenue at $189.5M. The company's backlog reached $2.36B, with $1.1B expected within 12 months. Analysts project 2026 revenue of ~$970M, potentially topping $1.5B in 2027 without Iridium. Rocket Lab plans to acquire Iridium for $8B, expected to close in mid-2027. Shares have a Strong Buy consensus with an avg. target of $110.13.

finance.biggo.com3 min
SEP 17
$RKLBMed

Rocket Lab Expands Launch Infrastructure and Vehicle Architecture to Capture Domestic Launch Market Share – SatNews

Rocket Lab, led by Peter Beck, is expanding its launch infrastructure and developing the Neutron medium-lift rocket to capture U.S. market share. The company operates launch complexes in New Zealand and Virginia, with plans for Cape Canaveral. Neutron, a reusable rocket, aims to compete in the 13,000-kilogram payload class. Rocket Lab's strategy includes vertical integration and targeting defense and commercial launches.

satnews.com2 min
SEP 17
$RKLBMed

Rocket Lab Jumps 6% as FCC Clears First Hurdle on Iridium Deal; Iridium Communications Barely Budges

Rocket Lab (RKLB) shares rose 6% after the FCC accepted its license-transfer applications for acquiring Iridium Communications (IRDM), opening a public-comment period. Iridium's stock barely moved, up 0.2%. The ARK Space Exploration & Innovation ETF (ARKX) gained 2%, outpacing the S&P 500 ETF (SPY). SpaceX has asked the FCC to examine Iridium's conduct toward rival satellite operators.

finance.yahoo.com2 min
SEP 17
$CBRSHighAI 8/10

Cerebras Drops 19% in 3 Months: Buy, Sell or Hold the Stock?

Cerebras Systems (CBRS) shares fell 19% in 3 months due to profitability concerns, margin pressure, and competition. Q3 2026 revenue guidance is $214-$216M, with margins expected to decline. The company faces customer concentration risks and competition from NVIDIA, AMD, and Intel. Despite strong RPO and expansion plans, near-term challenges persist. Analysts see a 56.93% upside potential.

theglobeandmail.com3 min